Ivo Radman

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).

Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).

Journal: Medicina (Kaunas, Lithuania)

Published: January 20, 2024

Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma.

Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma.

Journal: Medicine

Published: June 19, 2023

R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.

R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.

Journal: Annals of hematology

Published: June 25, 2020

Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.

Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 17, 2018

Author reply.

Author reply.

Journal: Internal medicine journal

Published: February 04, 2018

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study.

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 17, 2016

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.

Journal: Annals of hematology

Published: November 30, 2015

Nodular Prurigo Associated with Mycosis Fungoides - Case Report.

Nodular Prurigo Associated with Mycosis Fungoides - Case Report.

Journal: Acta dermatovenerologica Croatica : ADC

Published: October 19, 2015

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients.

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients.

Journal: Croatian medical journal

Published: June 20, 2015

Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature.

Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature.

Journal: Radiation oncology (London, England)

Published: June 16, 2013

Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).

Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).

Journal: Annals of hematology

Published: April 03, 2013

Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.

Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.

Journal: Acta haematologica

Published: October 10, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026